2026 Manfred Zierhut: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	National Ranking	Publications	Citations
Immunology	52	4059	272	309	9936

Overview

Manfred Zierhut was affiliated with the University of Tübingen in Germany and focused on medical research, particularly in the field of ophthalmology. Their scholarly contributions spanned a wide range of topics related to ocular diseases, immunology, and related systemic conditions.

Their main field of study was Medicine, with significant specialization in Ophthalmology. Additional subfields included Rheumatology, Epidemiology, Dermatology, and Oncology.

Manfred Zierhut's research addressed several major topics within ophthalmic and systemic conditions:

Ocular Diseases and Behçet's Syndrome
Retinal and Optic Conditions
Cytomegalovirus and Herpesvirus Research
Retinal Diseases and Treatments
Vasculitis and Related Conditions
Systemic Lupus Erythematosus Research
Ocular Infections and Treatments

Their work was published predominantly in the following venues:

Ocular Immunology and Inflammation
British Journal of Ophthalmology
Ophthalmology
JDDG Journal der Deutschen Dermatologischen Gesellschaft
Indian Journal of Ophthalmology

Among notable recent papers authored or co-authored by Zierhut were:

Ocular Adverse Events After COVID-19 Vaccination (2021), published in Ocular Immunology and Inflammation
COVID-19 and Immunosuppression: A Review of Current Clinical Experiences and Implications for Ophthalmology Patients Taking Immunosuppressive Drugs (2020), published in British Journal of Ophthalmology
COVID-19: Limiting the Risks for Eye Care Professionals (2020), published in Ocular Immunology and Inflammation
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma (2021), published in Ocular Immunology and Inflammation
Viral Anterior Uveitis (2020), published in Indian Journal of Ophthalmology

Their frequent collaborators included the following researchers:

Emmett T. Cunningham
Vishali Gupta
Rupesh Agrawal
Carlos Pavésio
Justine R. Smith

Best Publications

The use of interferon α in behçet disease: review of the literature

Ina Kötter;Ilhan Günaydin;Manfred Zierhut;Nicole Stübiger

293
Citations
Behçet's disease: Ocular effects and treatment

Christoph M E Deuter;Ina Kötter;Graham R Wallace;Philip I Murray

236
Citations
Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel

M. Schaller;L. M.C. Almeida;A. Bewley;B. Cribier

231
Citations
High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates

Irina Bonzheim;Sabrina Giese;Christoph Deuter;Daniela Süsskind

204
Citations
Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis

A. Heiligenhaus;H. Michels;C. Schumacher;I. Kopp

185
Citations
Ocular Adverse Events After COVID-19 Vaccination.

Xin Le Ng;Bjorn Kaijun Betzler;Ilaria Testi;Su Ling Ho

172
Citations
Immunology and functional genomics of Behçet's disease.

M. Zierhut;N. Mizuki;S. Ohno;H. Inoko

168
Citations
Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.

Anjo Riemens;Jacoline Bromberg;Valerie Touitou;Bianka Sobolewska

162
Citations
Differential efficacy of human recombinant interferon-α2a on ocular and extraocular manifestations of behçet disease: results of an open 4-center trial

Ina Kötter;Reinhard Vonthein;Manfred Zierhut;Anja Katrin Eckstein

139
Citations
Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.

Kirsten Siepmann;Matthias Huber;Nicole Stübiger;Christoph Deuter

118
Citations
Strengths and weaknesses of diagnostic tools for tuberculous uveitis.

Daniel V. Vasconcelos-Santos;Manfred Zierhut;Narsing A. Rao

117
Citations
Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study

Christoph M E Deuter;Ina Koetter;Ilhan Guenaydin;Nicole Stuebiger

109
Citations
Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases.

Torsten Schlote;Matthias Derse;Manfred Zierhut

105
Citations
Vaccine-Associated Uveitis.

Emmett T. Cunningham;Ramana S. Moorthy;Frederick W. Fraunfelder;Manfred Zierhut

96
Citations
Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

A Heiligenhaus;K Minden;Christoph Tappeiner;H Baus

81
Citations
COVID-19: Limiting the Risks for Eye Care Professionals.

Soumen Sadhu;Rupesh Agrawal;Rupesh Agrawal;Richa Pyare;Carlos Pavesio

81
Citations
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma

Denise Carbonell;Sarakshi Mahajan;Soon-Phaik Chee;Bianka Sobolewska

78
Citations
Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop

Rupesh Agrawal;Rupesh Agrawal;Rupesh Agrawal;Aniruddha Agarwal;Douglas A Jabs;Douglas A Jabs;Aera Kee

73
Citations
COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs.

Zheng Xian Thng;Marc D De Smet;Cecilia S Lee;Vishali Gupta

72
Citations
Viral anterior uveitis.

Kalpana Babu;Vinaya Kumar Konana;Sudha K Ganesh;Gazal Patnaik

71
Citations
Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behcet's disease.

Treusch M;Vonthein R;Baur M;Günaydin I

69
Citations
Tuberculosis or sarcoidosis: Opposite ends of the same disease spectrum?

Rupesh Agrawal;Rupesh Agrawal;Ae Ra Kee;Leslie Ang;Yeo Tun Hang

68
Citations
Mycophenolate mofetil (MMF) is a highly effective and safe immunosuppressive agent for the treatment of uveitis

M. Zierhut;M. Huber;N. Stuebiger;C. Deuter

1
Citations

Frequent Co-Authors

Martin Schaller University of Tübingen

Hans-Georg Rammensee University of Tübingen

Lothar Kanz University of Tübingen

Janet L. Davis University of Miami

Jennifer E. Thorne Johns Hopkins University

Denis Wakefield University of New South Wales

John V. Forrester University of Aberdeen

Andrew D. Dick University of Bristol

James T. Rosenbaum Oregon Health & Science University

Shigeaki Ohno Hokkaido University

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career avenues. Many professionals transition into clinical roles that align with immunological knowledge, such as nursing and patient care. Online education has made these pathways more accessible, offering flexible options tailored for different backgrounds.

If you’re coming from a non-nursing background but want to enter healthcare, online BSN programs for non nurses provide a direct route to becoming a registered nurse through specialized curriculum designed for career changers.

For faster entry into nursing, consider 12-month accelerated nursing programs, which compress key training into a shorter timeframe without compromising quality. These are ideal for motivated individuals seeking rapid progress.

Specific to family health, pursuing an accelerated FNP program can prepare you for advanced practice roles, integrating immunology principles with patient-centered care.

For entry-level nursing roles, exploring LPN schools easy to get into can help you start your healthcare journey quickly while gaining clinical experience relevant to immunology settings.